Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Enyedy Insider Profile
4 Followers
Mark Enyedy, Director at Fate Therapeutics, holds 0.00 shares in Fate Therapeutics (Ticker: FATE), holds 0.00 shares in ImmunoGen (Ticker: IMGN), holds 2.18K shares in BioMarin Pharmaceutical (Ticker: BMRN). Most recently, Mark Enyedy ― shares of Fate Therapeutics on ― for an estimated value of ―.
Mark Enyedy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Enyedy holds in companies
Most Profitable Insider Trade
Stock:
ImmunoGen
(IMGN)
(IMGN)
Rating:Informative Buy
Date:Nov 09, 2016 - Nov 09, 2017
Return:+187.10%
The most profitable trade made by Mark Enyedy
Mark Enyedy's Trading History
Fate Therapeutics
―
Director
―
$0.00
ImmunoGen
Feb 12, 2024
―
Uninformative Sell
―
$0.00
Keryx Biopharma
Dec 13, 2018
―
Uninformative Sell
―
$0.00
Akebia Therapeutics
Jun 09, 2020
Director
Uninformative Buy
―
$42.67K
Logicbio Therapeutics
Nov 17, 2022
―
Uninformative Sell
―
$0.00
BioMarin Pharmaceutical
Dec 28, 2023
Director
Uninformative Buy
―
$200.69K
List of latest transactions for each holding click on a transaction to see Mark Enyedy's performance on stock
You May Also Like
Mark Enyedy insider profile FAQ
What is the percentage of profitable transactions made by Mark Enyedy?
The percentage of profitable transactions made by Mark Enyedy is ―.
What is the average return per transaction made by Mark Enyedy?
The average return per transaction made by Mark Enyedy is ―.
What stocks does Mark Enyedy hold?
Mark Enyedy holds: FATE, IMGN, KERX, AKBA, LOGC, BMRN stocks.
What was Mark Enyedy’s latest transaction?
Mark Enyedy latest transaction was an Uninformative Buy of ―.
What was Mark Enyedy's most profitable transaction?
Mark Enyedy’s most profitable transaction was an Informative Buy of IMGN stock on November 9, 2016. The return on the trade was 187.10%.
What is Mark Enyedy's role in Fate Therapeutics?
Mark Enyedy's role in Fate Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.